Patients with challenging cases of atrial fibrillation (AFib) have a new treatment option now that the FDA has approved ...

Abbott, the global healthcare leader, announced today it has received U.S. Food and Drug Administration (FDA) approval for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ to treat patients with ...

Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...

The new device, which already gained CE mark approval, allows users to switch back and forth from one technique to the other ...

Abbott’s TactiFlex Duo dual-energy, sensor-enabled ablation catheter treats patients with difficult atrial fibrillation (AFib ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced FDA clearance of its EnSite Precision™ cardiac mapping system and Advisor™ FL ...

First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...

Abbott has received an FDA clearance for the latest version of its sensor-laden catheter used to map out the electrical activity of the heart muscle—a device the company says will help support its ...

More research finds mixed results with adjunctive procedures in persistent atrial fibrilla ...

Medtronic kicked off the week with news that it plans to strengthen its cardiac ablation buiness with the acquisition of Affera for an undisclosed sum. The deal also provides Medtronic with an entry ...